246 related articles for article (PubMed ID: 30529095)
1. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
[TBL] [Abstract][Full Text] [Related]
2. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
[TBL] [Abstract][Full Text] [Related]
3. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
[TBL] [Abstract][Full Text] [Related]
4. Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.
Chen D; Liu S; Chen S; Wang Z; Wu Z; Ma K; Fan J; Peng Z
Int J Clin Oncol; 2016 Dec; 21(6):1111-1119. PubMed ID: 27368337
[TBL] [Abstract][Full Text] [Related]
5. The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantation.
Lu D; Zhuo J; Yang M; Wang C; Pan L; Xie H; Xu X; Zheng S
Gene; 2018 Jul; 663():121-125. PubMed ID: 29627528
[TBL] [Abstract][Full Text] [Related]
6. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S
Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437
[TBL] [Abstract][Full Text] [Related]
7. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.
Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L
Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162
[TBL] [Abstract][Full Text] [Related]
8. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between genetic polymorphisms in cytokine genes and tumor recurrence in patients with hepatocellular carcinoma undergoing transplantation.
Wu LM; Zhou L; Xu J; Wei BJ; Cheng J; Xu X; Xi B; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):54-9. PubMed ID: 23392799
[TBL] [Abstract][Full Text] [Related]
10. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L
BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in the one-carbon metabolism pathway genes and susceptibility to hepatocellular carcinoma risk: a case-control study.
Zhang H; Liu C; Han YC; Ma Z; Zhang H; Ma Y; Liu X
Tumour Biol; 2015 Feb; 36(2):997-1002. PubMed ID: 25318605
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation.
Zheng Z; Gao S; Yang Z; Xie H; Zhang C; Lin B; Wu L; Zheng S; Zhou L
Int J Med Sci; 2014; 11(2):142-50. PubMed ID: 24465159
[TBL] [Abstract][Full Text] [Related]
13. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T
Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006
[TBL] [Abstract][Full Text] [Related]
14. Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation.
Zhang T; Liu Y; Peng X; Fan J; Peng Z
Dis Markers; 2017; 2017():1754696. PubMed ID: 29162948
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms of XRCC3 gene in hepatocellular carcinoma - relationship with clinicopathological features.
Avadanei ER; Giusca SE; Negura L; Caruntu ID
Pol J Pathol; 2018; 69(1):73-81. PubMed ID: 29895130
[TBL] [Abstract][Full Text] [Related]
16. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.
Lautem A; Simon F; Hoppe-Lotichius M; Mittler J; Vollmar J; Schad A; Düber C; Galle PR; Otto G; Zimmermann T; Lang H
Oncol Rep; 2019 Apr; 41(4):2299-2310. PubMed ID: 30720132
[TBL] [Abstract][Full Text] [Related]
18. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
[TBL] [Abstract][Full Text] [Related]
19. The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers.
Moruzzi S; Udali S; Ruzzenente A; Guglielmi A; Guarini P; Martinelli N; Conci S; Mazzi F; Pattini P; Tammen SA; Olivieri O; Pizzolo F; Choi SW; Friso S
PLoS One; 2016; 11(12):e0167534. PubMed ID: 27936032
[TBL] [Abstract][Full Text] [Related]
20.
de la Fuente S; Citores MJ; Lucena JL; Muñoz P; Cuervas-Mons V
Biomark Med; 2019 Aug; 13(12):995-1004. PubMed ID: 31317790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
